Polymerfri biolimus-eluerende stents eller polymerbaserede zotarolimus-eluerende stents til koronar bifurkation læsioner
Background: A polymer-free biolimus-eluting stent (PF-BES) and a zotarolimus-eluting stent (ZES) just lately confirmed comparable medical profiles and seem like competing choices in particular medical settings of sufferers present process percutaneous coronary intervention (PCI). Whether or not they carry out equally additionally in complicated procedural settings as coronary bifurcation lesions stays unaddressed.
Strategies: All consecutive sufferers present process coronary bifurcation PCI with PF-BES or the brand new iteration of the ZES from three giant multicenter real-world registries had been included. The first consequence was main antagonistic cardiovascular occasions (MACE), a composite of all-cause demise, myocardial infarction (MI), goal lesion revascularization (TLR) and stent thrombosis (ST).
A number of analyses to regulate for baseline variations had been carried out together with propensity-score matching, propensity-score stratification and inverse-probability-weighting. Outcomes are reported in response to Cox proportional hazard fashions censored at 400-day follow-up.
Outcomes: 1169 sufferers handled with PF-BES (n = 440) or ZES (n = 729) on the primary department of a coronary bifurcation lesion had been included (imply age 69 ± 11 years, 75.4% male, 53.8% acute coronary syndrome at presentation, 26.6% left primary bifurcation, median twin antiplatelet remedy period 12 [range 12-12] months). MACE, all-cause demise, TLR and ST tended in the direction of non-statistically larger charges with the PF-BES as in comparison with the ZES. Larger MI and goal vessel revascularization prevalence was noticed with PF-BES.
Conclusions: On this giant modern cohort of sufferers present process coronary bifurcation PCI, the prevalence of MACE was non-statistically totally different with the usage of PF-BES and ZES gadgets.
Nevertheless, variations favoring the ZES system which will entail medical relevance had been noticed. Additional research are wanted to substantiate these findings and discover whether or not they stay legitimate when a brief twin antiplatelet remedy is adopted.
Key phrases: Coronary artery illness; Coronary bifurcation; Percutaneous coronary intervention; Polymer-free biolimus-eluting stent; Zotarolimus-eluting stent
Calf thymus DNA |
|||
T13592-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Calf thymus DNA |
Calf thymus DNA |
|||
T13592-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Calf thymus DNA |
Calf thymus DNA |
|||
T13592-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Calf thymus DNA |
Calf thymus DNA |
|||
T13592-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Calf thymus DNA |
Calf thymus DNA |
|||
MBS5754258-10mg | MyBiosource | 10mg | EUR 220 |
Calf thymus DNA |
|||
MBS5754258-25mg | MyBiosource | 25mg | EUR 365 |
Calf thymus DNA |
|||
MBS5754258-2mg | MyBiosource | 2mg | EUR 135 |
Calf thymus DNA |
|||
MBS5754258-50mg | MyBiosource | 50mg | EUR 625 |
Calf thymus DNA |
|||
MBS5754258-5mg | MyBiosource | 5mg | EUR 175 |
DNA, Denatured Calf Thymus |
|||
40490044-1 | Glycomatrix | 10 mg | EUR 65.14 |
DNA, Denatured Calf Thymus |
|||
40490044-2 | Glycomatrix | 20 mg | EUR 114.09 |
OORA00209-v1 - DNA (Calf Thymus) |
|||
OORA00209-v1 | Aviva Systems Biology | 100mg | EUR 125 |
OORA00210-25MG - DNA (Calf Thymus) |
|||
OORA00210-25MG | Aviva Systems Biology | 25mg | EUR 179 |
OORA00209-100MG - DNA (Calf Thymus) |
|||
OORA00209-100MG | Aviva Systems Biology | 100mg | EUR 119 |
DNA, Calf Thymus (Deoxyribonucleic acid) |
|||
MBS653508-100mg | MyBiosource | 100mg | EUR 300 |
DNA, Calf Thymus (Deoxyribonucleic acid) |
|||
MBS653508-1g | MyBiosource | 1g | EUR 575 |
DNA, Calf Thymus (Deoxyribonucleic acid) |
|||
MBS653508-5g | MyBiosource | 5g | EUR 1925 |
DNA, Calf Thymus (Deoxyribonucleic acid) |
|||
MBS653508-5x5g | MyBiosource | 5x5g | EUR 8510 |
RNase-Free Calf Thymus DNA, 1 mg/mL (5x1mL) |
|||
9-31065 | Biotium |
|
|
Description: Minimum order quantity: 1 unit of 5tubes |
RNase-Free Calf Thymus DNA, 1 mg/mL (1 mL) |
|||
31065-1 | Biotium | EA | EUR 261 |
BOVINE, CALF, THYMUS, FRESH |
|||
8601156 | Lampire Biologicals Laboratories | 1G | EUR 67.09 |
BOVINE, CALF, THYMUS, FROZEN |
|||
8621156 | Lampire Biologicals Laboratories | 1G | EUR 67.09 |
Calf Thymus Acetone Powder |
|||
E61A00101 | EnoGene | 5g | EUR 100 |
Calf Thymus Acetone Powder |
|||
E61A00102 | EnoGene | 10g | EUR 175 |
Calf Thymus Acetone Powder |
|||
E61A00103 | EnoGene | 100g | EUR 1500 |
Calf Thymus Acetone Powder |
|||
MBS8506722-5g | MyBiosource | 5g | EUR 680 |
Calf Thymus Acetone Powder |
|||
MBS8506722-5x5g | MyBiosource | 5x5g | EUR 2905 |
Calf Thymus Acetone Powder |
|||
MBS8506755-10g | MyBiosource | 10g | EUR 255 |
Calf Thymus Acetone Powder |
|||
MBS8506755-5x10g | MyBiosource | 5x10g | EUR 1005 |
Calf Thymus Acetone Powder |
|||
MBS8506831-100g | MyBiosource | 100g | EUR 1590 |
Calf Thymus Acetone Powder |
|||
MBS8506831-5x100g | MyBiosource | 5x100g | EUR 6995 |
Nucleohistone Thymus (calf) |
|||
N15210 | Pfaltz & Bauer | 100MG | EUR 578.7 |
La/SS-B Antigen, Calf Thymus |
|||
MBS651604-10mg | MyBiosource | 10mg | EUR 545 |
La/SS-B Antigen, Calf Thymus |
|||
MBS651604-5x10mg | MyBiosource | 5x10mg | EUR 2310 |
BOVINE, CALF, FETAL, THYMUS, FRESH |
|||
8601156.2 | Lampire Biologicals Laboratories | 1G | EUR 81.74 |
BOVINE, CALF, FETAL, THYMUS, FROZEN |
|||
8621156.2 | Lampire Biologicals Laboratories | 1G | EUR 81.74 |
Deoxyribonucleic acid sodium salt from calf thymus |
|||
abx082051-100mg | Abbexa | 100 mg | EUR 276 |
Deoxyribonucleic Acid Sodium Salt from Calf Thymus |
|||
05658-44 | NACALAI TESQUE | 100MG | EUR 42.7 |
Deoxyribonucleic acid sodium salt from calf thymus |
|||
abx082051-100l | Abbexa | 100 µl | EUR 200 |
Deoxyribonucleic acid sodium salt from calf thymus |
|||
abx082051-1ml | Abbexa | 1 ml | Ask for price |
Deoxyribonucleic acid sodium salt from calf thymus |
|||
abx082051-200l | Abbexa | 200 µl | Ask for price |
Purified Native dsDNA, Calf Thymus, ELISA/Antigen grade |
|||
DNAD25-N-1 | Alpha Diagnostics | 1 mg | EUR 196.8 |
Purified Native ssDNA, Calf Thymus, ELISA/Antigen grade |
|||
DNAS35-N-1 | Alpha Diagnostics | 1 mg | EUR 270 |
Deoxyribonucleic Acid Sodium Salt (DNA Sodium Salt Highly Polymerized) ex. Calf Thymus extrapure |
|||
68451 | Sisco Laboratories | 25 Mg | EUR 20.63 |
Description: Part B |
Deoxyribonucleic acid (sodium, from calf thymus, Type I, fibers) |
|||
HY-153118 | MedChemExpress | 10 mg | EUR 54.11 |
Description: Deoxyribonucleic acid (sodium, from calf thymus, Type I, fibers) is the sodium salts form of Calf thymus DNA (HY-109517). Calf thymus DNA is a double-stranded template DNA isolated from calf thymus. It can be used to study the interaction between DNA and DNA binding agents, as well as the structure and function of DNA, for DNA quantification and used as a substrate for DNA polymerase analysis, etc[1][2][3]. |
Human Thymus Genomic DNA |
|||
HG-702 | Zyagen | 0.05mg | EUR 210 |
Genomic DNA - Rat Normal Tissue: Thymus |
|||
D1434264 | Biochain | 100 ug | EUR 329 |
Mouse Thymus, match set of RNA, DNA, Protein |
|||
MS-702-RDP | Zyagen | 20µg/20µg/100µg | EUR 422 |
Tissue, Genomic DNA, Rat Adult Normal, Thymus, BioGenomics |
|||
MBS654456-01mg | MyBiosource | 0.1mg | EUR 575 |
Tissue, Genomic DNA, Rat Adult Normal, Thymus, BioGenomics |
|||
MBS654456-5x01mg | MyBiosource | 5x0.1mg | EUR 2440 |
Thymus Lysate |
|||
1471 | ProSci | 0.1 mg | EUR 229.2 |
Description: Thymus tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
Thymus Factor |
|||
GWB-A72648 | GenWay Biotech | 1 mg | Ask for price |
Thymus Factor |
|||
070-77 | PHOENIX PEPTIDE | 500 μg | EUR 50.76 |
Thymus, Rabbit |
|||
MBS639337-25Each | MyBiosource | 25Each | EUR 370 |
Thymus, Rabbit |
|||
MBS639337-5x25Each | MyBiosource | 5x25Each | EUR 1450 |
Thymus Factor |
|||
MBS826394-10mg | MyBiosource | 10mg | EUR 290 |
Thymus Factor |
|||
MBS826394-1mg | MyBiosource | 1mg | EUR 150 |
Thymus Factor |
|||
MBS826394-5mg | MyBiosource | 5mg | EUR 215 |
Thymus Factor |
|||
MBS826394-5x10mg | MyBiosource | 5x10mg | EUR 1195 |
Thymus Lysate |
|||
MBS151621-01mg | MyBiosource | 0.1mg | EUR 200 |
Thymus Lysate |
|||
MBS151621-5x01mg | MyBiosource | 5x0.1mg | EUR 880 |
Thymus Lysate |
|||
MBS151715-01mg | MyBiosource | 0.1mg | EUR 200 |
Thymus Lysate |
|||
MBS151715-5x01mg | MyBiosource | 5x0.1mg | EUR 880 |
Thymus Lysate |
|||
MBS151748-01mg | MyBiosource | 0.1mg | EUR 200 |
Thymus Lysate |
|||
MBS151748-5x01mg | MyBiosource | 5x0.1mg | EUR 880 |
Dog Thymus RNA* |
|||
DR-702 | Zyagen | 0.05mg | EUR 195 |
Dog Thymus cDNA* |
|||
DD-702 | Zyagen | 30 Reactions | EUR 319 |
Cat Thymus cDNA |
|||
FD-702 | Zyagen | 30 Reactions | EUR 319 |
Pig Thymus cDNA |
|||
PD-702 | Zyagen | 30 reactions | EUR 243 |
Rat Thymus cDNA |
|||
RD-702 | Zyagen | 30 reactions | EUR 243 |
Thymus factor X |
|||
HY-P0001 | MedChemExpress | 1mg | EUR 357.6 |
Thymus factor X |
|||
TP1030-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Thymus factor X |
Thymus factor X |
|||
TP1030-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Thymus factor X |
Thymus factor X |
|||
TP1030-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Thymus factor X |
Thymus factor X |
|||
TP1030-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Thymus factor X |
Thymus factor X |
|||
TP1030-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Thymus factor X |
Thymus factor X |
|||
MBS5763355-1mg | MyBiosource | 1mg | EUR 240 |
Thymus factor X |
|||
MBS5763355-5mg | MyBiosource | 5mg | EUR 690 |
Thymus factor X |
|||
MBS5763355-5x5mg | MyBiosource | 5x5mg | EUR 2950 |
Thymus peptide C |
|||
HY-P0070 | MedChemExpress | 5mg | EUR 639.6 |
Sheep Thymus cDNA |
|||
SD-702 | Zyagen | 30 reactions | EUR 243 |
Thymus peptide C |
|||
TP1694-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Thymus peptide C |
Thymus peptide C |
|||
TP1694-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Thymus peptide C |
Thymus peptide C |
|||
TP1694-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Thymus peptide C |
Thymus peptide C |
|||
TP1694-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Thymus peptide C |
Thymus peptide C |
|||
TP1694-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Thymus peptide C |
Thymus peptide C |
|||
MBS5763744-5mg | MyBiosource | 5mg | EUR 375 |
Thymus peptide C |
|||
MBS5763744-5x5mg | MyBiosource | 5x5mg | EUR 1530 |
Equine Thymus cDNA |
|||
ED-702 | Zyagen | 30 reactions | EUR 319 |
Bovine Thymus cDNA |
|||
BD-702 | Zyagen | 30 reactions | EUR 243 |
Rabbit Thymus cDNA |
|||
TD-702 | Zyagen | 30 reactions | EUR 243 |
PARG (bovine thymus) |
|||
MBS566099-01Unit | MyBiosource | 0.1Unit | EUR 640 |
PARG (bovine thymus) |
|||
MBS566099-5x01Unit | MyBiosource | 5x0.1Unit | EUR 2815 |
Thymus Tissue block |
|||
26 | BioCoreUSA | 1 unit | EUR 635 |
Chicken Thymus cDNA* |
|||
CD-702 | Zyagen | 30 reactions | EUR 243 |
Hamster Thymus cDNA |
|||
AD-702 | Zyagen | 30 reactions | EUR 243 |
Fetal Thymus Lysate |
|||
XBL-10426 | ProSci | 0.1 mg | EUR 500.1 |
Description: Fetal human thymus tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The fetal human thymus tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the thymus tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The thymus tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
MiniPig Thymus cDNA |
|||
ND-702 | Zyagen | 30 reactions | EUR 446 |
Thymus Powder (porcine) |
|||
PTP-010 | Creative Enzymes | 1kg | EUR 525 |
Thymus Membrane Lysate |
|||
XBL-10978 | ProSci | 0.1 mg | EUR 991.5 |
Description: Human thymus tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human thymus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated thymus tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated thymus tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
OORA00348-10U - THYMUS |
|||
OORA00348-10U | Aviva Systems Biology | 1Each | EUR 155 |
OORA00348-1EA - THYMUS |
|||
OORA00348-1EA | Aviva Systems Biology | 1Each | EUR 149 |
OORA00490-10U - THYMUS |
|||
OORA00490-10U | Aviva Systems Biology | 1Each | EUR 55 |
OORA00490-1EA - THYMUS |
|||
OORA00490-1EA | Aviva Systems Biology | 1Each | EUR 59 |
Chicken Thymus Sections |
|||
CP-702 | Zyagen | 10 slides | EUR 240 |
Thymus Cytoplasmic Lysate |
|||
XBL-10977 | ProSci | 0.1 mg | EUR 273.3 |
Description: Human thymus tissue cytoplasmic protein lysate was prepared by isolating the cytoplasmic protein from whole tissue homogenates using a proprietary technique. The human thymus tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The cytoplasmic protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, glycerol, and a cocktail of protease inhibitors. For quality control purposes, the isolated thymus tissue cytoplasmic protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated thymus tissue cytoplasmic protein is then Western analyzed by GAPDH antibody, and the expression level is consistent with each lot. |
Cat Thymus Total RNA* |
|||
FR-702 | Zyagen | 0.05mg | EUR 195 |
Pig Thymus Total RNA |
|||
PR-702 | Zyagen | 0.1mg | EUR 160 |
Rat Thymus Total RNA |
|||
RR-702 | Zyagen | 0.05mg | EUR 160 |
Mouse CD1 Thymus cDNA |
|||
MD-702 | Zyagen | 30 reactions | EUR 243 |
Mouse BLC Thymus cDNA |
|||
MD-702-BLC | Zyagen | 30 reactions | EUR 280 |
Mouse C57 Thymus cDNA |
|||
MD-702-C57 | Zyagen | 30 reactions | EUR 280 |
Human Thymus Total RNA |
|||
HR-702 | Zyagen | 0.05mg | EUR 172 |
Guinea Pig Thymus cDNA |
|||
GD-702 | Zyagen | 30 reactions | EUR 243 |
Sheep Thymus Total RNA |
|||
SR-702 | Zyagen | 0.1mg | EUR 160 |
Bovine Thymus Total RNA |
|||
BR-702 | Zyagen | 0.1mg | EUR 160 |
Equine Thymus Total RNA |
|||
ER-702 | Zyagen | 0.1mg | EUR 195 |
Rabbit Thymus Total RNA* |
|||
TR-702 | Zyagen | 0.05mg | EUR 160 |
Dog Thymus Total Protein |
|||
DT-702 | Zyagen | 1mg | EUR 176 |
Hamster Thymus Total RNA* |
|||
AR-702 | Zyagen | 0.05mg | EUR 160 |
Chicken Thymus Total RNA* |
|||
CR-702 | Zyagen | 0.05mg | EUR 160 |
Cat Thymus Total Protein |
|||
FT-702 | Zyagen | 1mg | EUR 176 |
Pig Thymus Total Protein |
|||
PT-702 | Zyagen | 1mg | EUR 153 |
MiniPig Thymus Total RNA |
|||
NR-702 | Zyagen | 0.1mg | EUR 319 |
Rat Thymus Tissue Lysate |
|||
LYSATE0008 | BosterBio | 200ug | EUR 180 |
Description: This cell lysate is prepared from rat thymus tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
Rat Thymus Total Protein |
|||
RT-702 | Zyagen | 0.5mg | EUR 153 |
OORA00549-1U - Rat THYMUS |
|||
OORA00549-1U | Aviva Systems Biology | 1Each | EUR 60 |
Monkey Thymus cDNA, Rhesus |
|||
UD-702 | Zyagen | 30 reactions | EUR 316 |
Dna Calf Activated Di - EACH |
|||
27457501 | Scientific Laboratory Supplies | EACH | EUR 409.05 |
Dog Thymus Frozen Sections |
|||
DF-702 | Zyagen | 10 slides | EUR 261 |
Cat Thymus Frozen Sections |
|||
FF-702 | Zyagen | 10 slides | EUR 261 |
Human Thymus Tissue Lysate |
|||
IHUTYMTL100UG | Innovative research | each | EUR 245 |
Description: Human Thymus Tissue Lysate |
OORA00549-1EA - Rat THYMUS |
|||
OORA00549-1EA | Aviva Systems Biology | 1Each | EUR 59 |
Pig Thymus Frozen Sections |
|||
PF-702 | Zyagen | 10 slides | EUR 261 |
Mouse Thymus Tissue Lysate |
|||
LYSATE0019 | BosterBio | 200ug | EUR 180 |
Description: This cell lysate is prepared from mouse thymus tissue using Boster's RIPA Lysis Buffer (AR0105) using a standard whole cell lysate protocol. The concentration was determined using the BCA assay process and then diluted using Dithiothreitol (DTT) and a reducing SDS sample loading buffer, heated for 5 minutes at 100˚C. |
Rat Thymus Frozen Sections |
|||
RF-702 | Zyagen | 10 slides | EUR 228 |
Sheep Thymus Total Protein |
|||
ST-702 | Zyagen | 1mg | EUR 153 |
Human Thymus Tissue Lysate |
|||
MBS8420132-01mg | MyBiosource | 0.1mg | EUR 385 |
Human Thymus Tissue Lysate |
|||
MBS8420132-5x01mg | MyBiosource | 5x0.1mg | EUR 1540 |
Bovine Thymus Total Protein |
|||
BT-702 | Zyagen | 1mg | EUR 153 |
Equine Thymus Total protein |
|||
ET-702 | Zyagen | 1mg | EUR 176 |
Rabbit Thymus Total Protein |
|||
TT-702 | Zyagen | 1mg | EUR 153 |
Dog Thymus paraffin Sections |
|||
DP-702 | Zyagen | 10 slides | EUR 240 |
Chicken Thymus Total Protein |
|||
CT-702 | Zyagen | 0.5mg | EUR 153 |
Hamster Thymus Total Protein |
|||
AT-702 | Zyagen | 1mg | EUR 153 |
Konjugering af antistof med temperaturresponsiv polymer through in situ klikreaktion for at muliggøre biomarkørberigelse for øget diagnostisk følsomhed
Early prognosis of infectious illnesses is without doubt one of the present prevalent challenges, particularly in low and restricted useful resource settings the place easy, quick, transportable, low-cost, and delicate diagnostic approaches are wanted.
Lateral movement immunoassay (LFIA) is a typical, speedy screening assay. Nevertheless, the low assay sensitivity limits the utility of LFIA for specimens with low pathogenic hundreds (early an infection phases). Antibodies conjugated with stimulus-responsive polymers have been beforehand utilized to enhance assay sensitivity for detection of biomarkers at low concentrations.
Nevertheless, the lack of antibody affinity after polymer conjugation stays a major problem. On this examine, we developed poly(N-isopropylacrylamide-co-N-(2-hydroxyisopropyl)acrylamide-co-strained alkyne-isopropylacrylamide), a novel polymer for biomarker enrichment, by polymer conjugation after antibody-antigen recognition.
We employed and promoted the clicking chemistry in situ, to facilitate extremely particular conjugation between novel temperature-responsive polymers and antibody-antigen complexes.
This methodology may suppress the lower within the binding fixed related to polymer conjugation (>20-fold). The conjugation was efficiently demonstrated in physique fluids corresponding to urine and saliva. We achieved >5-fold antigen enrichment through thermal precipitation by conjugating polymers to the antibodies after antigen recognition.
Concentrated biomarkers resulted in improved LFIA detection. This strategy can probably be utilized to enhance diagnostic exams for infectious illnesses in low and restricted useful resource settings.
Kationskabelonassisteret RAFT-cyclopolymerisation af hexa (ethylenglycol) Di (meth) acrylater til termoresponsive pseudokronetherpolymerer
Cation template-assisted reversible addition fragmentation/chain switch (RAFT) cyclopolymerization of hexa(ethylene glycol) diacrylate (PEG6DA) or hexa(ethylene glycol) dimethacrylate (PEG6DMA) is developed as a flexible system to provide giant in-chain ring cyclopolymers, thermoresponsive pseudo-crown ether polymers.
For an environment friendly synthesis, potassium hexafluorophosphate (KPF6 ) is employed as a cation template; PEG6DA in addition to PEG6DMA acknowledges the potassium cation with the hexa(ethylene glycol) spacer to dynamically type a pseudo-cyclic divinyl monomer.
These monomers interacting with the potassium cations are effectively polymerized with RAFT brokers and radical initiators into cyclopolymers comprising 24-membered hexa(ethylene glycol) rings.
The cation template-assisted RAFT cyclopolymerization can also be efficient for the synthesis of amphiphilic random cyclocopolymers bearing hydrophilic hexa(ethylene glycol) rings and hydrophobic butyl teams. Cyclopolymers of PEG6DA and PEG6DMA additional present thermoresponsive solubility in water. The cloud level temperature of cyclopoly(PEG6DA)s is larger than that of a cyclopoly(PEG6DMA).
En fantomundersøgelse til kontrast og sammenligning af polymer- og guldfiduciale markører i strålebehandling simulationsbilleddannelse
To evaluate visibility and artifact traits of polymer fiducials in comparison with normal gold fiducials for radiotherapy CT and MRI simulation. Three gold and three polymer fiducials had been inserted right into a CT and MRI tissue-equivalent phantom that approximated the prostate most cancers radiotherapy configuration.
The phantom and fiducials had been imaged on CT and MRI. Pictures had been assessed when it comes to fiducial visibility and artifact. ImageJ was employed to quantify the pixel gray-scale of every fiducial and artifact.
Fiducial gray-scale histograms and profiles had been generated for evaluation. Goal measurements of the contrast-to-noise ratio (CNR), signal-to-noise ratio (SNR), and artifact index (AI) had been calculated.
The CT pictures confirmed that the gold fiducials are visually brighter, with higher distinction than the polymer. The upper peak values illustrate this within the line profiles. Nevertheless, they produce vibrant radiating and darkish shadowing artifacts.
That is depicted by the higher width of line profiles and the disruption of phantom space profiles. Quantitatively this ends in higher percentile ranges of the histograms. Moreover, for CT, gold had the next CNR than polymer, relative to the phantom.
Nevertheless, the gold CNR and SNR had been degraded by the higher artifact and thus AI. Each fiducials had been seen on MRI and had comparable histograms and profiles that had been additionally mirrored in comparable CNR, SNR and AI. Polymer fiducials had been nicely visualized in a phantom on CT and MR and produce much less artifact than the gold fiducials. Polymer markers may improve the standard and accuracy of radiotherapy co-registration and planning however require medical affirmation.
BLU-554 |
|||
B8391-100 | ApexBio | 100mg | EUR 1507 |
BLU-554 |
|||
B8391-5 | ApexBio | 5mg | EUR 174 |
BLU-554 |
|||
B8391-50 | ApexBio | 50mg | EUR 870 |
BLU-554 |
|||
B2359-1 | Biovision | each | EUR 144 |
BLU-554 |
|||
B2359-5 | Biovision | each | EUR 392.4 |
BLU-554 |
|||
MBS131490-100mg | MyBiosource | 100mg | EUR 1495 |
BLU-554 |
|||
MBS579587-100mg | MyBiosource | 100mg | EUR 990 |
BLU-554 |
|||
MBS579587-10mg | MyBiosource | 10mg | EUR 260 |
BLU-554 |
|||
MBS579587-1mg | MyBiosource | 1mg | EUR 155 |
BLU-554 |
|||
MBS579587-50mg | MyBiosource | 50mg | EUR 605 |
BLU-554 |
|||
MBS579587-5mg | MyBiosource | 5mg | EUR 195 |
BLU-554 |
|||
MBS3602606-10mg | MyBiosource | 10mg | EUR 390 |
BLU-554 |
|||
MBS3602606-25mg | MyBiosource | 25mg | EUR 725 |
BLU-554 |
|||
MBS3602606-2mg | MyBiosource | 2mg | EUR 250 |
BLU-554 |
|||
MBS3602606-5mg | MyBiosource | 5mg | EUR 315 |
BLU-554 |
|||
MBS3602606-5x25mg | MyBiosource | 5x25mg | EUR 2945 |
BLU-9931 |
|||
MBS130781-100mg | MyBiosource | 100mg | EUR 1065 |
BLU-9931 |
|||
MBS130781-500mg | MyBiosource | 500mg | EUR 2775 |
BLU-263 |
|||
T9295-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: BLU-263 |
BLU-263 |
|||
T9295-1g | TargetMol Chemicals | 1g | Ask for price |
Description: BLU-263 |
BLU-263 |
|||
T9295-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: BLU-263 |
BLU-945 |
|||
T9754-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: BLU-945 |
BLU-945 |
|||
T9754-1g | TargetMol Chemicals | 1g | Ask for price |
Description: BLU-945 |
BLU-945 |
|||
T9754-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: BLU-945 |
BLU-945 |
|||
T9754-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: BLU-945 |
BLU-945 |
|||
T9754-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: BLU-945 |
BLU-263 |
|||
T9295-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: BLU-263 |
BLU-263 |
|||
T9295-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: BLU-263 |
Blu-782 |
|||
T8108-10mg | TargetMol Chemicals | 10mg | Ask for price |
Description: Blu-782 |
Blu-782 |
|||
T8108-1g | TargetMol Chemicals | 1g | Ask for price |
Description: Blu-782 |
Blu-782 |
|||
T8108-1mg | TargetMol Chemicals | 1mg | Ask for price |
Description: Blu-782 |
Blu-782 |
|||
T8108-50mg | TargetMol Chemicals | 50mg | Ask for price |
Description: Blu-782 |
Blu-782 |
|||
T8108-5mg | TargetMol Chemicals | 5mg | Ask for price |
Description: Blu-782 |
BLU-945 |
|||
MBS5801399-10mg | MyBiosource | 10(mg | EUR 895 |
BLU-945 |
|||
MBS5801399-1mg | MyBiosource | 1(mg | EUR 325 |
BLU-945 |
|||
MBS5801399-5mg | MyBiosource | 5(mg | EUR 540 |
BLU-263 |
|||
MBS5786217-10mg | MyBiosource | 10(mg | EUR 470 |
BLU-263 |
|||
MBS5786217-1mg | MyBiosource | 1(mg | EUR 210 |
BLU-263 |
|||
MBS5786217-5mg | MyBiosource | 5(mg | EUR 335 |
BLU-782 |
|||
MBS132903-INQUIRE | MyBiosource | INQUIRE | Ask for price |
Blu-782 |
|||
MBS3611166-10mg | MyBiosource | 10mg | EUR 495 |
Blu-782 |
|||
MBS3611166-25mg | MyBiosource | 25mg | EUR 775 |
Blu-782 |
|||
MBS3611166-5mg | MyBiosource | 5mg | EUR 345 |
Blu-782 |
|||
MBS3611166-5x25mg | MyBiosource | 5x25mg | EUR 3185 |
Blu-782 |
|||
MBS5758933-10mg | MyBiosource | 10mg | EUR 430 |
Blu-782 |
|||
MBS5758933-1mg | MyBiosource | 1mg | EUR 185 |
Blu-782 |
|||
MBS5758933-25mg | MyBiosource | 25mg | EUR 715 |
Blu-782 |
|||
MBS5758933-5mg | MyBiosource | 5mg | EUR 280 |
Blu-782 |
|||
MBS5758933-5x25mg | MyBiosource | 5x25mg | EUR 3070 |
BLU-945 |
|||
HY-144680 | MedChemExpress | 10 mg | EUR 1385.3 |
Description: BLU-945 is a potent, highly selective, reversible and orally active epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKIs). BLU-945 can effectively inhibit EGFR with L858R and/or exon 19 deletion mutation, T790M mutation and C797S mutation. BLU-945 can be used for the research of lung cancer including non-small cell lung cancer (NSCLC)[1][2][3]. |
Blu 9931 |
|||
20-abx183889 | Abbexa |
|
|
BLU antibody |
|||
22462 | SAB | 100ul | EUR 479 |
BLU antibody |
|||
22462-100ul | SAB | 100ul | EUR 468 |
BLU antibody |
|||
70R-13110 | Fitzgerald | 100 ul | EUR 550 |
Description: Affinity purified Rabbit polyclonal BLU antibody |
BLU antibody |
|||
MBS9410938-01mL | MyBiosource | 0.1mL | EUR 420 |
BLU antibody |
|||
MBS9410938-5x01mL | MyBiosource | 5x0.1mL | EUR 1740 |
BLU antibody |
|||
MBS835407-01mL | MyBiosource | 0.1mL | EUR 1070 |
BLU antibody |
|||
MBS835407-5x01mL | MyBiosource | 5x0.1mL | EUR 4655 |
BLU-667 (Pralsetinib) |
|||
B2548-1 | Biovision | each | EUR 170.4 |
BLU-667 (Pralsetinib) |
|||
B2548-5 | Biovision | each | EUR 496.8 |
Avapritinib?BLU-285 |
|||
MBS131631-100mg | MyBiosource | 100mg | EUR 1065 |
Avapritinib?BLU-285 |
|||
MBS131631-500mg | MyBiosource | 500mg | EUR 2925 |
Recombinant Human BLU |
|||
MBS7608948-005mg | MyBiosource | 0.05mg | EUR 470 |
Recombinant Human BLU |
|||
MBS7608948-02mg | MyBiosource | 0.2mg | EUR 885 |
Recombinant Human BLU |
|||
MBS7608948-1mg | MyBiosource | 1mg | EUR 2540 |
Recombinant Human BLU |
|||
MBS7608948-5x1mg | MyBiosource | 5x1mg | EUR 9820 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) |
|||
MBS6008009-02mL | MyBiosource | 0.2(mL | EUR 695 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) |
|||
MBS6008009-5x02mL | MyBiosource | 5x0.2mL | EUR 2975 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) |
|||
MBS6011271-02mL | MyBiosource | 0.2(mL | EUR 695 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) |
|||
MBS6011271-5x02mL | MyBiosource | 5x0.2mL | EUR 2975 |
Rat Bluetongue virus(Blu)ELISA Kit |
|||
SL1336Ra | Sunlong | - | Ask for price |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (AP) |
|||
MBS6365458-02mL | MyBiosource | 0.2mL | EUR 980 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (AP) |
|||
MBS6365458-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (APC) |
|||
MBS6365459-02mL | MyBiosource | 0.2mL | EUR 980 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (APC) |
|||
MBS6365459-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (PE) |
|||
MBS6365468-02mL | MyBiosource | 0.2mL | EUR 980 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (PE) |
|||
MBS6365468-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (AP) |
|||
MBS6365469-02mL | MyBiosource | 0.2mL | EUR 980 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (AP) |
|||
MBS6365469-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (APC) |
|||
MBS6365470-02mL | MyBiosource | 0.2mL | EUR 980 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (APC) |
|||
MBS6365470-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (PE) |
|||
MBS6365479-02mL | MyBiosource | 0.2mL | EUR 980 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (PE) |
|||
MBS6365479-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (FITC) |
|||
MBS6365461-02mL | MyBiosource | 0.2mL | EUR 980 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (FITC) |
|||
MBS6365461-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (FITC) |
|||
MBS6365472-02mL | MyBiosource | 0.2mL | EUR 980 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (FITC) |
|||
MBS6365472-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (Biotin) |
|||
MBS6365460-02mL | MyBiosource | 0.2mL | EUR 980 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (Biotin) |
|||
MBS6365460-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (Biotin) |
|||
MBS6365471-02mL | MyBiosource | 0.2mL | EUR 980 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (Biotin) |
|||
MBS6365471-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (MaxLight 405) |
|||
MBS6365463-01mL | MyBiosource | 0.1mL | EUR 980 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (MaxLight 405) |
|||
MBS6365463-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (MaxLight 490) |
|||
MBS6365464-01mL | MyBiosource | 0.1mL | EUR 980 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (MaxLight 490) |
|||
MBS6365464-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (MaxLight 550) |
|||
MBS6365465-01mL | MyBiosource | 0.1mL | EUR 980 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (MaxLight 550) |
|||
MBS6365465-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (MaxLight 650) |
|||
MBS6365466-01mL | MyBiosource | 0.1mL | EUR 980 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (MaxLight 650) |
|||
MBS6365466-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (MaxLight 750) |
|||
MBS6365467-01mL | MyBiosource | 0.1mL | EUR 980 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (MaxLight 750) |
|||
MBS6365467-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (MaxLight 405) |
|||
MBS6365474-01mL | MyBiosource | 0.1mL | EUR 980 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (MaxLight 405) |
|||
MBS6365474-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (MaxLight 490) |
|||
MBS6365475-01mL | MyBiosource | 0.1mL | EUR 980 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (MaxLight 490) |
|||
MBS6365475-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (MaxLight 550) |
|||
MBS6365476-01mL | MyBiosource | 0.1mL | EUR 980 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (MaxLight 550) |
|||
MBS6365476-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (MaxLight 650) |
|||
MBS6365477-01mL | MyBiosource | 0.1mL | EUR 980 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (MaxLight 650) |
|||
MBS6365477-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (MaxLight 750) |
|||
MBS6365478-01mL | MyBiosource | 0.1mL | EUR 980 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (MaxLight 750) |
|||
MBS6365478-5x01mL | MyBiosource | 5x0.1mL | EUR 4250 |
BLU (ZMYND10) (NM_015896) Human Recombinant Protein |
|||
PROTO75800 | BosterBio | 20ug | EUR 1249 |
Description: Recombinant protein of human zinc finger, MYND-type containing 10 (ZMYND10) |
Human Blue-tongue virus (BLU) ELISA Kit |
|||
SL3344Hu | Sunlong | 96 Tests | EUR 468 |
Bovine Blue-tongue virus (BLU) ELISA Kit |
|||
SL0058Bo | Sunlong | - | EUR 528 |
PAST B7541 Ø25(7) BLU 2022 AB Labels |
|||
834795 | BRADY NV | Pack of 175 Label(s) | EUR 114.92 |
Description: Description Dutch: Vervaldagaanduiding-DATE 22 Dia 25 B-7541; Description French: PASTILLES CALENDRIER 22 Dia 25 B-7541 |
PAST B7541 Ø25(7) BLU 2029 AB Labels |
|||
834802 | BRADY NV | Pack of 175 Label(s) | EUR 114.92 |
Description: Description Dutch: Vervaldagaanduiding-DATE 29 Dia 25 B-7541; Description French: PASTILLES CALENDRIER 29 Dia 25 B-7541 |
PAST B7541 Ø35(5) BLU 2022 AB Labels |
|||
834813 | BRADY NV | Pack of 125 Label(s) | EUR 114.92 |
Description: Description Dutch: Vervaldagaanduiding-DATE 22 Dia 35 B-7541; Description French: PASTILLES CALENDRIER 22 Dia 35 B-7541 |
PAST B7541 Ø35(5) BLU 2029 AB Labels |
|||
834820 | BRADY NV | Pack of 125 Label(s) | EUR 114.92 |
Description: Description Dutch: Vervaldagaanduiding-DATE 29 Dia 35 B-7541; Description French: PASTILLES CALENDRIER 29 Dia 35 B-7541 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (Azide free) (HRP) |
|||
MBS6365462-02mL | MyBiosource | 0.2mL | EUR 980 |
ZMYND10, CT (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (Azide free) (HRP) |
|||
MBS6365462-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (Azide free) (HRP) |
|||
MBS6365473-02mL | MyBiosource | 0.2mL | EUR 980 |
ZMYND10, ID (ZMYND10, BLU, Zinc finger MYND domain-containing protein 10, Protein BLu) (Azide free) (HRP) |
|||
MBS6365473-5x02mL | MyBiosource | 5x0.2mL | EUR 4250 |